Skip to content

Stock Information for IKT

Overview of IKT

IKT, also known as Inhibikase Therapeutics Inc, is a company in the Health Care sector. Inhibikase Therapeutics Inc's website is https://www.inhibikase.com.

Market Capitalization

IKT has a market cap of $133.04 million with 67,192,570.00 shares outstanding as of Mon, Nov 11, 2024.

Stock Charts

The IKT stock charts offer a comprehensive, real-time view of Inhibikase Therapeutics Inc's stock performance. Powered by TradingView, these interactive charts provide investors with a dynamic and detailed visualization of IKT's market activity.

Key features of the IKT stock charts include:

  • Real-Time Data: Get up-to-the-minute updates on Inhibikase Therapeutics Inc's stock price, ensuring you have the latest information at your fingertips.
  • Customizable Time Frames: Analyze IKT's performance over various periods, from intraday movements to long-term trends. Easily switch between daily, weekly, monthly, and yearly views.
  • Technical Indicators: Utilize a wide array of technical indicators, such as moving averages, RSI, MACD, and more, to perform in-depth analysis of IKT's stock movements.
  • Drawing Tools: Enhance your analysis with TradingView's extensive drawing tools. Add trend lines, channels, Fibonacci retracements, and other annotations to your charts.
  • Comparative Analysis: Compare IKT's performance against other stocks, indices, or financial instruments to gain a broader market perspective.
  • User-Friendly Interface: The interactive nature of the charts allows you to zoom in, pan across different periods, and hover over data points for detailed information, making it easy to track and analyze IKT's stock performance.

Whether you're a day trader looking for quick insights or a long-term investor analyzing market trends, the IKT stock charts provide all the tools you need to make informed decisions. Dive into the data and explore how Inhibikase Therapeutics Inc is performing in the market today.




Comprehensive Stock Forecast for IKT

Understanding the future trajectory of a stock is crucial for investors, and IKT is no exception. With numerous analysts and financial experts weighing in, it’s essential to have a comprehensive overview of what to expect. Below, we explore various aspects of the IKT stock forecast, drawing insights from different time frames and sources to provide a well-rounded perspective.

The forecast for IKT extends through multiple years, with detailed projections for 2024, 2025, 2029, 2034, and even as far as 2034. These projections are based on various factors, including market trends, financial health, and overall economic conditions. Notable sources such as FintechZoom, CNN Money, Zacks, and WalletInvestor offer diverse viewpoints, ensuring that investors get a holistic understanding of the potential growth or decline of IKT.

In the short term, predictions for IKT in the upcoming months or years (2024, 2025, 2029) are often influenced by current market performance and recent financial reports. For the long term, forecasts for 2029, 2034, and beyond consider broader economic indicators and industry trends. Analysts also provide specific outlooks, like the 5-year forecast, to help investors plan their strategies accordingly.

Moreover, platforms like CNBC and Yahoo Finance provide detailed analysis and expert opinions that contribute significantly to the stock’s forecast. Whether you’re looking for tomorrow’s prediction or the long-term outlook, these insights are invaluable. By examining forecasts from various credible sources, investors can make informed decisions based on a well-rounded view of the potential future of IKT.

IKT Dividend History

Discover the detailed dividend history for IKT. This section provides an overview of the dividends distributed by Inhibikase Therapeutics Inc over the years. You'll find information on payout dates, dividend amounts, and historical dividend yield, helping you understand the company's track record of returning value to its shareholders.

View Details

IKT Stock Split History

Explore the stock split history for IKT. In this section, you will find detailed records of all stock splits undertaken by Inhibikase Therapeutics Inc. Understand how each split has affected the stock's price and share count, providing insights into the company's growth and strategies to make shares more affordable for investors.

View Details